Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.
Silvestri B, Bandieri E, Del Prete S, Ianniello GP, Micheletto G, Dambrosio M, Sabbatini G, Endrizzi L, Marra A, Aitini E, Calorio A, Garetto F, Nastasi G, Piantedosi F, Sidoti V, Spanu P. Silvestri B, et al. Clin Drug Investig. 2008;28(7):399-407. doi: 10.2165/00044011-200828070-00001. Clin Drug Investig. 2008. PMID: 18544000 Clinical Trial.
Low-dose buprenorphine infusion to prevent postoperative hyperalgesia in patients undergoing major lung surgery and remifentanil infusion: a double-blind, randomized, active-controlled trial.
Mercieri M, Palmisani S, De Blasi RA, D'Andrilli A, Naccarato A, Silvestri B, Tigano S, Massullo D, Rocco M, Arcioni R. Mercieri M, et al. Among authors: silvestri b. Br J Anaesth. 2017 Oct 1;119(4):792-802. doi: 10.1093/bja/aex174. Br J Anaesth. 2017. PMID: 29121294 Free article. Clinical Trial.
Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874].
Chiarion-Sileni V, Del Bianco P, Romanini A, Guida M, Paccagnella A, Dalla Palma M, Naglieri E, Ridolfi R, Silvestri B, Michiara M, De Salvo GL. Chiarion-Sileni V, et al. Among authors: silvestri b. BMC Cancer. 2006 Feb 27;6:44. doi: 10.1186/1471-2407-6-44. BMC Cancer. 2006. PMID: 16504154 Free PMC article. Clinical Trial.
Invasive neurostimulation.
Mercieri M, Arcioni R, Palmisani S, Vano V, Tigano S, Smith T, Del Fiore MR, Silvestri B, Al-Kaisy A, Martelletti P. Mercieri M, et al. Among authors: silvestri b. J Headache Pain. 2015 Dec;16(Suppl 1):A29. doi: 10.1186/1129-2377-16-S1-A29. J Headache Pain. 2015. PMID: 28132359 Free PMC article. No abstract available.
Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020).
Bertino G, Groselj A, Campana LG, Kunte C, Schepler H, Gehl J, Muir T, Clover JAP, Quaglino P, Kis E, Mascherini M, Bisase B, Pecorari G, Bechara F, Matteucci P, Odili J, Russano F, Orlando A, Pritchard-Jones R, Moir G, Mowatt D, Silvestri B, Seccia V, Saxinger W, de Terlizzi F, Sersa G. Bertino G, et al. Among authors: silvestri b. Front Oncol. 2022 Sep 20;12:951662. doi: 10.3389/fonc.2022.951662. eCollection 2022. Front Oncol. 2022. PMID: 36203425 Free PMC article.
Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. IV. Differential activation of human Th1 and Th2 lymphocytes and influence of the atopic status on lymphoma development.
Coppola V, Veronesi A, Indraccolo S, Calderazzo F, Mion M, Minuzzo S, Esposito G, Mauro D, Silvestri B, Gallo P, Falagiani P, Amadori A, Chieco-Bianchi L. Coppola V, et al. Among authors: silvestri b. J Immunol. 1998 Mar 1;160(5):2514-22. J Immunol. 1998. PMID: 9498797
83 results